Soleno Therapeutics, Inc. (SLNO) Secures EMA Validation for PWS Treatment VYKAT XR
Soleno Therapeutics, Inc.
Soleno Therapeutics Inc (SLNO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Vivo Capital Albert Cha And Frank Kung | 4,458,294 | $318,545,106 | -30% | 42.19% |
| 2. | Adage Capital Management Phill Gross And Robert Atchinson | 4,392,696 | $313,858,129 | +59% | 0.58% |
| 3. | VenBio Select Advisor Kurt Von Emster | 2,525,000 | $180,411,250 | 2.82% | |
| 4. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 1,757,023 | $125,539,293 | -56% | 4.99% |
| 5. | Citadel Investment Group Ken Griffin | 1,576,044 | $112,608,344 | +63% | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.00 | 250,000 | Large Shareholder | 3,074,542 | 2023-09-28 | Filing | |
| $21.00 | 36,939 | Large Shareholder | 2,824,542 | 2023-09-26 | Filing | |
| $20.03 | 117,996 | Large Shareholder | 2,787,603 | 2023-09-26 | Filing | |
| $19.11 | 88,685 | Large Shareholder | 2,669,607 | 2023-09-26 | Filing | |
| $18.24 | 52,691 | Large Shareholder | 2,580,922 | 2023-09-26 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $70.11 | 3,782 | 27,036 | 2025-04-01 | Filing | ||
| $71.55 | 5,937 | 6,500 | 2025-03-28 | Filing | ||
| $66.95 | 23,475 | 28,143 | 2025-03-27 | Filing | ||
| $66.00 | 50,156 | 51,618 | 2025-03-27 | Filing | ||
| $72.64 | 91 | 61,136 | 2025-03-27 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,140,899 | $370,024,378 | 0.2% | |
| 2. | 2,233,473 | $159,581,640 | 0.01% | |
| 3. | 1,913,326 | $136,707,143 | 0% | |
| 4. | 1,866,326 | $133,348,993 | 0% | |
| 5. | 1,211,245 | $86,543,455 | 0.42% |
News See All
11 Best Performing Healthcare Stocks to Buy Now
On April 15, CNBC reported that President Trump's healthcare-focused executive order brought in a win for the sector.
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Q1 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Soleno Therapeutics First Quarter 2025 Earnings Conference Call. At this time, note that all participants are in a listen-only mode.
Top 10 Small Cap Stocks to Buy with the Highest Upside Potential
On December 30, MJP Wealth Advisors chief investment officer Brian Vendig appeared on Yahoo! Finance's Catalysts to discuss the potential outlook of small cap stocks in 2025.
10 Biggest Stocks with Negative Beta to Consider
Beta is a measurement of market risk or volatility that indicates how much the price of a stock tends to fluctuate up and down compared to other stocks.
10 Most Promising Small-Cap Stocks According to Hedge Funds
Small-cap stocks are offering a myriad of opportunities to investors and are expected to go higher.
Oppenheimer's Favorite Stocks For Next 12 Months: Top 32 Stock Picks
The tail end of August is appearing to turn a fresh page for Wall Street.
15 Stocks That Will 10x in 5 Years According to the Analysts
In this article, we discuss the 15 stocks that will 10x in 5 years according to analysts.
5 Best Performing NASDAQ Stocks in 2023
In this piece, we will take a look at the five best performing NASDAQ stocks in 2023.
5 Best Performing Biotech Stocks in 2023
In this piece, we will take a look at the five best performing biotechnology stocks in 2023.
Billionaire Hedge Funds
